Covid-19 Impact on Infection Control Market, Global Research Reports 2020-2021

SKU ID :QYR-15646819 | Published Date: 11-May-2020 | No. of pages: 91
1.1 Research Scope 1.2 Market Segmentation 1.3 Research Objectives 1.4 Research Methodology 1.4.1 Research Process 1.4.2 Data Triangulation 1.4.3 Research Approach 1.4.4 Base Year 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.5.2 Covid-19 Impact: Commodity Prices Indices 1.5.3 Covid-19 Impact: Global Major Government Policy 1.6 The Covid-19 Impact on Infection Control Industry 1.7 COVID-19 Impact: Infection Control Market Trends 2 Global Infection Control Quarterly Market Size Analysis 2.1 Infection Control Business Impact Assessment - COVID-19 2.1.1 Global Infection Control Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 2.2 Global Infection Control Quarterly Market Size 2020-2021 2.3 COVID-19-Driven Market Dynamics and Factor Analysis 2.3.1 Drivers 2.3.2 Restraints 2.3.3 Opportunities 2.3.4 Challenges 3 Quarterly Competitive Assessment, 2020 3.1 By Players, Global Infection Control Quarterly Market Size, 2019 VS 2020 3.2 By Players, Infection Control Headquarters and Area Served 3.3 Date of Key Players Enter into Infection Control Market 3.4 Key Players Infection Control Product Offered 3.5 Mergers & Acquisitions, Expansion Plans 4 Impact of Covid-19 on Infection Control Segments, By Type 4.1 Introduction 1.4.1 Disinfection Products 1.4.2 Sterilization Products and Services 4.2 By Type, Global Infection Control Market Size, 2019-2021 5 Impact of Covid-19 on Infection Control Segments, By Application 5.1 Overview 5.5.1 Hospitals & Clinics 5.5.2 Life Sciences Industry 5.5.3 Medical Device Companies 5.5.4 Pharmaceutical Companies 5.5.5 Food Industry 5.5.6 Other 5.2 By Application, Global Infection Control Market Size, 2019-2021 5.2.1 By Application, Global Infection Control Market Size by Application, 2019-2021 6 Geographic Analysis 6.1 Introduction 6.2 North America 6.2.1 Macroeconomic Indicators of US 6.2.2 US 6.2.3 Canada 6.3 Europe 6.3.1 Macroeconomic Indicators of Europe 6.3.2 Germany 6.3.3 France 6.3.4 UK 6.3.5 Italy 6.4 Asia-Pacific 6.4.1 Macroeconomic Indicators of Asia-Pacific 6.4.2 China 6.4.3 Japan 6.4.4 South Korea 6.4.5 India 6.4.6 ASEAN 6.5 Rest of World 6.5.1 Latin America 6.5.2 Middle East and Africa 7 Company Profiles 7.1 STERIS 7.1.1 STERIS Business Overview 7.1.2 STERIS Infection Control Quarterly Revenue, 2020 7.1.3 STERIS Infection Control Product Introduction 7.1.4 STERIS Response to COVID-19 and Related Developments 7.2 Getinge 7.2.1 Getinge Business Overview 7.2.2 Getinge Infection Control Quarterly Revenue, 2020 7.2.3 Getinge Infection Control Product Introduction 7.2.4 Getinge Response to COVID-19 and Related Developments 7.3 Ecolab 7.3.1 Ecolab Business Overview 7.3.2 Ecolab Infection Control Quarterly Revenue, 2020 7.3.3 Ecolab Infection Control Product Introduction 7.3.4 Ecolab Response to COVID-19 and Related Developments 7.4 3M 7.4.1 3M Business Overview 7.4.2 3M Infection Control Quarterly Revenue, 2020 7.4.3 3M Infection Control Product Introduction 7.4.4 3M Response to COVID-19 and Related Developments 7.5 Advanced Sterilization Products 7.5.1 Advanced Sterilization Products Business Overview 7.5.2 Advanced Sterilization Products Infection Control Quarterly Revenue, 2020 7.5.3 Advanced Sterilization Products Infection Control Product Introduction 7.5.4 Advanced Sterilization Products Response to COVID-19 and Related Developments 7.6 Cantel Medical 7.6.1 Cantel Medical Business Overview 7.6.2 Cantel Medical Infection Control Quarterly Revenue, 2020 7.6.3 Cantel Medical Infection Control Product Introduction 7.6.4 Cantel Medical Response to COVID-19 and Related Developments 7.7 Sotera Health 7.7.1 Sotera Health Business Overview 7.7.2 Sotera Health Infection Control Quarterly Revenue, 2020 7.7.3 Sotera Health Infection Control Product Introduction 7.7.4 Sotera Health Response to COVID-19 and Related Developments 7.8 MMM Group 7.8.1 MMM Group Business Overview 7.8.2 MMM Group Infection Control Quarterly Revenue, 2020 7.8.3 MMM Group Infection Control Product Introduction 7.8.4 MMM Group Response to COVID-19 and Related Developments 7.9 Matachana 7.9.1 Matachana Business Overview 7.9.2 Matachana Infection Control Quarterly Revenue, 2020 7.9.3 Matachana Infection Control Product Introduction 7.9.4 Matachana Response to COVID-19 and Related Developments 7.10 Belimed AG 7.10.1 Belimed AG Business Overview 7.10.2 Belimed AG Infection Control Quarterly Revenue, 2020 7.10.3 Belimed AG Infection Control Product Introduction 7.10.4 Belimed AG Response to COVID-19 and Related Developments 7.11 Halyard Health 7.11.1 Halyard Health Business Overview 7.11.2 Halyard Health Infection Control Quarterly Revenue, 2020 7.11.3 Halyard Health Infection Control Product Introduction 7.11.4 Halyard Health Response to COVID-19 and Related Developments 7.12 Metrex Research 7.12.1 Metrex Research Business Overview 7.12.2 Metrex Research Infection Control Quarterly Revenue, 2020 7.12.3 Metrex Research Infection Control Product Introduction 7.12.4 Metrex Research Response to COVID-19 and Related Developments 7.13 Reckitt Benckiser 7.13.1 Reckitt Benckiser Business Overview 7.13.2 Reckitt Benckiser Infection Control Quarterly Revenue, 2020 7.13.3 Reckitt Benckiser Infection Control Product Introduction 7.13.4 Reckitt Benckiser Response to COVID-19 and Related Developments 7.14 Pal International 7.14.1 Pal International Business Overview 7.14.2 Pal International Infection Control Quarterly Revenue, 2020 7.14.3 Pal International Infection Control Product Introduction 7.14.4 Pal International Response to COVID-19 and Related Developments 8 Key Findings 9 Appendix 9.1 About US 9.2 Disclaimer
List of Tables Table 1. Overview of the World Economic Outlook Projections Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity) Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 7. Covid-19 Impact: Global Major Government Policy Table 8. The Covid-19 Impact on Infection Control Assessment Table 9. COVID-19 Impact: Infection Control Market Trends Table 10. COVID-19 Impact Global Infection Control Market Size Table 11. Global Infection Control Quarterly Market Size, 2020 (US$ Million) Table 12. Global Infection Control Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million) Table 13. Global Infection Control Market Growth Drivers Table 14. Global Infection Control Market Restraints Table 15. Global Infection Control Market Opportunities Table 16. Global Infection Control Market Challenges Table 17. By Players, Infection Control Quarterly Revenue, 2019 VS 2020 (US$ Million) Table 18. Key Players, Infection Control Revenue Market Share, 2019 VS 2020 (%) Table 19. Key Infection Control Players Headquarters and Area Served Table 20. Date of Key Players Enter into Infection Control Market Table 21. Key Players Infection Control Product Type Table 22. Mergers & Acquisitions, Expansion Plans Table 23. By Players, Global Infection Control Market Size 2019-2021, (US$ Million) Table 24. Global Infection Control Market Size by Application: 2019-2021 (US$ Million) Table 25. Global Infection Control Market Size by Region, 2019-2021 (US$ Million) Table 26. By Country, North America Infection Control Market Size, 2019-2021 (US$ Million) Table 27. By Type, US Infection Control Market Size, 2019-2021 (US$ Million) Table 28. By Application, US Infection Control Market Size, 2019-2021 (US$ Million) Table 29. By Type, Canada Infection Control Market Size, 2019-2021 (US$ Million) Table 30. By Application, Canada Infection Control Market Size, 2019-2021 (US$ Million) Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy) Table 32. By Country, Europe Infection Control Market Size, 2019-2021 (US$ Million) Table 33. By Type, Germany Infection Control Market Size, 2019-2021 (US$ Million) Table 34. By Application, Germany Infection Control Market Size, 2019-2021 (US$ Million) Table 35. By Type, France Infection Control Market Size, 2019-2021 (US$ Million) Table 36. By Application, France Infection Control Market Size, 2019-2021 (US$ Million) Table 37. By Type, UK Infection Control Market Size, 2019-2021 (US$ Million) Table 38. By Application, UK Infection Control Market Size, 2019-2021 (US$ Million) Table 39. By Type, Italy Infection Control Market Size, 2019-2021 (US$ Million) Table 40. By Application, Italy Infection Control Market Size, 2019-2021 (US$ Million) Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN) Table 42. By Region, Asia-Pacific Infection Control Market Size, 2019-2021 (US$ Million) Table 43. By Type, China Infection Control Market Size, 2019-2021 (US$ Million) Table 44. By Application, China Infection Control Market Size, 2019-2021 (US$ Million) Table 45. By Type, Japan Infection Control Market Size, 2019-2021 (US$ Million) Table 46. By Application, Japan Infection Control Market Size, 2019-2021 (US$ Million) Table 47. By Type, South Korea Infection Control Market Size, 2019-2021 (US$ Million) Table 48. By Application, South Korea Infection Control Market Size, 2019-2021 (US$ Million) Table 49. By Type, India Infection Control Market Size, 2019-2021 (US$ Million) Table 50. By Application, India Infection Control Market Size, 2019-2021 (US$ Million) Table 51. By Type, ASEAN Infection Control Market Size, 2019-2021 (US$ Million) Table 52. By Application, ASEAN Infection Control Market Size, 2019-2021 (US$ Million) Table 53. By Type, Latin America Infection Control Market Size, 2019-2021 (US$ Million) Table 54. By Application, Latin America Infection Control Market Size, 2019-2021 (US$ Million) Table 55. By Type, Middle East and Africa Infection Control Market Size, 2019-2021 (US$ Million) Table 56. By Application, Middle East and Africa Infection Control Market Size, 2019-2021 (US$ Million) Table 57. STERIS Business Overview Table 58. STERIS Infection Control Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 59. STERIS Infection Control Product Table 60. STERIS Response to COVID-19 and Related Developments Table 61. Getinge Business Overview Table 62. Getinge Infection Control Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 63. Getinge Infection Control Product Table 64. Getinge Response to COVID-19 and Related Developments Table 65. Ecolab Business Overview Table 66. Ecolab Infection Control Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 67. Ecolab Infection Control Product Table 68. Ecolab Response to COVID-19 and Related Developments Table 69. 3M Business Overview Table 70. 3M Infection Control Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 71. 3M Infection Control Product Table 72. 3M Response to COVID-19 and Related Developments Table 73. Advanced Sterilization Products Business Overview Table 74. Advanced Sterilization Products Infection Control Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 75. Advanced Sterilization Products Infection Control Product Table 76. Advanced Sterilization Products Response to COVID-19 and Related Developments Table 77. Cantel Medical Business Overview Table 78. Cantel Medical Infection Control Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 79. Cantel Medical Infection Control Product Table 80. Cantel Medical Response to COVID-19 and Related Developments Table 81. Sotera Health Business Overview Table 82. Sotera Health Infection Control Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 83. Sotera Health Infection Control Product Table 84. Sotera Health Response to COVID-19 and Related Developments Table 85. MMM Group Business Overview Table 86. MMM Group Infection Control Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 87. MMM Group Infection Control Product Table 88. MMM Group Response to COVID-19 and Related Developments Table 89. Matachana Business Overview Table 90. Matachana Infection Control Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 91. Matachana Infection Control Product Table 92. Matachana Response to COVID-19 and Related Developments Table 93. Belimed AG Business Overview Table 94. Belimed AG Infection Control Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 95. Belimed AG Infection Control Product Table 96. Belimed AG Response to COVID-19 and Related Developments Table 97. Halyard Health Business Overview Table 98. Halyard Health Infection Control Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 99. Halyard Health Infection Control Product Table 100. Halyard Health Response to COVID-19 and Related Developments Table 101. Metrex Research Business Overview Table 102. Metrex Research Infection Control Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 103. Metrex Research Infection Control Product Table 104. Metrex Research Response to COVID-19 and Related Developments Table 105. Reckitt Benckiser Business Overview Table 106. Reckitt Benckiser Infection Control Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 107. Reckitt Benckiser Infection Control Product Table 108. Reckitt Benckiser Response to COVID-19 and Related Developments Table 109. Pal International Business Overview Table 110. Pal International Infection Control Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 111. Pal International Infection Control Product Table 112. Pal International Response to COVID-19 and Related Developments List of Figures Figure 1. Infection Control Product Picture Figure 2. Infection Control Market Segmentation Figure 3. Research Objectives Figure 4. Research Process Figure 5. Data Triangulation Figure 6. Research Approach Figure 7. Commodity Prices-Metals Price Indices Figure 8. Commodity Prices- Precious Metal Price Indices Figure 9. Commodity Prices- Agricultural Raw Material Price Indices Figure 10. Commodity Prices- Food and Beverage Price Indices Figure 11. Commodity Prices- Fertilizer Price Indices Figure 12. Commodity Prices- Energy Price Indices Figure 13. G20+: Economic Policy Responses to COVID-19 Figure 14. Global Infection Control Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million) Figure 15. Global Infection Control Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%) Figure 16. Global Infection Control Market Size, Quarterly Growth, 2020-2021 (%) Figure 17. Global Infection Control Market Size, Market Share by Type, 2019 VS 2020 (%) Figure 18. Global Infection Control Market Size, Market Share by Application, 2019 VS 2020 (%) Figure 19. Global Infection Control Market Size Market Share by Region, 2019 VS 2020 (%) Figure 20. United States Composite PMI and GDP Figure 21. Eurozone Composite PMI and GDP Figure 22. Eurozone Core v. Periphery PMI Output Indices Figure 23. Core v. Periphery PMI Employment Indices Figure 24. UK Composite PMI and GDP Figure 25. Caixin China Composite Output Index Figure 26. Caixin China General Services Business Activity Index Figure 27. Japan Composite Output Index Figure 28. South Korea Manufacturing PMI Figure 29. India Composite Output Index Figure 30. ASEAN Manufacturing PMI Figure 31. By Region, Asia-Pacific Infection Control Market Size Market Share, 2019-2021
STERIS Getinge Ecolab 3M Advanced Sterilization Products Cantel Medical Sotera Health MMM Group Matachana Belimed AG Halyard Health Metrex Research Reckitt Benckiser Pal International
  • PRICE
  • $3250
    $6500
    Buy Now

Our Clients